However, the point mutations in IDH1 are characterized by loss of normal function and gain of an unusual new activity of reducing α-KG to d-2HG in an NADPH consuming reaction [173,174], thereby, exacerbating the already high oxidative stress in gliomas. This evidence concerns the gene IDH1 and central nervous system cancer.